1. Home
  2. MAN vs IRON Comparison

MAN vs IRON Comparison

Compare MAN & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ManpowerGroup

MAN

ManpowerGroup

SELL

Current Price

$41.52

Market Cap

2.5B

ML Signal

SELL

Logo Disc Medicine Inc.

IRON

Disc Medicine Inc.

SELL

Current Price

$56.71

Market Cap

2.4B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
MAN
IRON
Founded
1948
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.4B
IPO Year
1994
2020

Fundamental Metrics

Financial Performance
Metric
MAN
IRON
Price
$41.52
$56.71
Analyst Decision
Buy
Strong Buy
Analyst Count
12
13
Target Price
$52.33
★ $103.17
AVG Volume (30 Days)
★ 991.7K
567.8K
Earning Date
10-15-2026
11-05-2026
Dividend Yield
★ 3.47%
N/A
EPS Growth
N/A
★ N/A
EPS
★ 1.19
N/A
Revenue
★ $17,957,100,000.00
N/A
Revenue This Year
$6.49
N/A
Revenue Next Year
$3.49
N/A
P/E Ratio
$34.81
★ N/A
Revenue Growth
★ 0.58
N/A
52 Week Low
$25.15
$40.00
52 Week High
$63.88
$99.50

Technical Indicators

Market Signals
Indicator
MAN
IRON
Relative Strength Index (RSI) 20.20 25.35
Support Level $29.25 $40.00
Resistance Level $57.29 $82.89
Average True Range (ATR) 2.52 2.62
MACD -1.23 -0.35
Stochastic Oscillator 3.93 15.32

Price Performance

Historical Comparison
MAN
IRON

About MAN ManpowerGroup

ManpowerGroup Inc provides workforce solutions and services, including recruitment and assessment, upskilling, reskilling, training and development, career management, outsourcing, and workforce consulting. The company leverages its trusted brands, industry knowledge, and AI-enabled assessments and offers an extensive portfolio of training and leadership development solutions. Its reportable segments are Staffing and Interim, Outcome-Based Solutions and Consulting, Permanent Recruitment, and Others, with Staffing and Interim generating the majority of revenue. It operates in the Americas, Southern Europe, Northern Europe, and APME. The company derives the maximum geographical revenue from the Southern European region.

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

Share on Social Networks: